1. Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection. (4th July 2022) Authors: Bavaro, DF; Diella, L; Solimando, AG; Cicco, S; Buonamico, E; Stasi, C; Ciannarella, M; Marrone, M; Carpagnano, F; Resta, O; Carpagnano, GE; Palmieri, VO; Vacca, A; Dell'Aera, M; Dell'Erba, A; Migliore, G; Aricò, M; Saracino, A Journal: Pathogens and global health Issue: Volume 116:Number 5(2022) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗